Delivery Order SPE2DB22D2007-SPE2DB25FJ3FY
- Not listed
- This is a $1,668.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ALBUMIN (HUMAN) 25% IV SOLN 50ML. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This delivery order is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.20 firm-fixed-price delivery order is for the supply of Albumin (Human) 25% IV Solution, a pharmaceutical product used in medical care. The contract has an ultimate completion date of November 13, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albumin (Human) 5% IV Solution 250ML. The contract has a ceiling value of $2,511.60 and a performance period ending on July 28, 2025. The contract is not set aside and was awarded on July 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,040.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Albumin (Human) 25% IV Solution, a critical medical product, with a performance period extending through May 13, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albumin (Human) 25% IV Solution, 100 milliliters, with a ceiling value of $4,992.48 and a completion date of July 28, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $8,512 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 250ml bottles of 5% human albumin intravenous solution. The contract has a period of performance from August 9th to August 30th, 2023, with all work to be performed by the prime contractor in Conshohocken, Pennsylvania. The Defense Logistics Agency utilizes indefinite-delivery/indefinite-quantity contracts to support medical material needs across the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.10 firm fixed-price delivery order is for the supply of Albumin (Human) 25% IV Solution, 50 ML, with a period of performance through July 31, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,552.78, is for the delivery of 100 ml bottles of 25% Albumin (Human) Intravenous Solution. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a $1,506.96 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Albumin (Human) 5% IV Solution 250ML, a critical medical product. The award has an ultimate completion date of May 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Albumin (Human) 25% IV Solution in 50 mL vials. It is a Firm Fixed Price Delivery Order contract with a ceiling value of $1,040.20 and a completion date of July 25, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3FYDelivery Order
The Defense Logistics Agency awarded a $2,080.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Albumin (Human) 25% intravenous solution in 50ml units. The contract, which is not set-aside, will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with DLA, leveraging the contractor's established capability to meet federal medical procurement requirements. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor to the Defense Health Agency and other military healthcare systems, AmerisourceBergen supplies a comprehensive portfolio of medications and medical commodities to support global military operations. The current delivery order for human albumin, a critical blood plasma substitute used in medical treatment and emergency response, demonstrates the contractor's ongoing role in fulfilling specialized pharmaceutical requirements across the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/23/25 |